Swedish biotech company Melt&Marble has raised €7.3 million in a Series A funding round to scale production of its precision-fermented designer fats and move toward commercial launch. The company develops high-performance, animal-free fats that serve as sustainable alternatives to traditional oils and fats used in global food and personal care markets. The new investment marks a significant step in Melt&Marble’s progression from R&D to full commercialization.
Strategic Backing for Commercial Scale-Up
The Series A round was led by deep-tech investor Industrifonden, with participation from the European Innovation Council Fund, Beiersdorf, Valio, Chalmers Ventures, and Catalyze Capital. Together with the €2.5 million EIC Accelerator grant awarded last year, Melt&Marble has secured more than €10 million in new capital over the past 12 months. This level of support signals strong confidence in the company’s technical readiness, market relevance, and scalability.
Beiersdorf and Valio bring strategic value across personal care and food, reinforcing the importance of advanced fats in both categories. Their involvement strengthens Melt&Marble’s co-development efforts and supports the integration of precision-designed fats into next-generation formulations.
CEO Anastasia Krivoruchko called the Series A a major milestone in the company’s transition from research to commercialization. She noted that key scalability targets have already been achieved and that this new funding places the company on a clear path to market entry.
Innovating Beyond Conventional Fats
Melt&Marble’s technology addresses well-known limitations in traditional fats, including sustainability concerns, supply instability, and performance constraints. By using precision fermentation, the company engineers yeast to produce tailored fat structures that deliver superior functionality for both food and personal care applications.
In food, these designer fats can improve texture, melt behavior, and sensory characteristics in meat and dairy alternatives, bakery products, confectionery, and other categories. In beauty, the company is developing lipids that enhance skin feel, softness, and overall product performance. Designing fats at the molecular level allows for better technical consistency while reducing environmental impact compared with palm, coconut, or animal-derived fats.
Investors have emphasized Melt&Marble’s unusually strong technical maturity for a company at this stage, noting that demand for sustainable and high-performance fats is growing rapidly across consumer industries.
A Clear Path to a $100 Billion Market
The new funding will enable Melt&Marble to scale from demonstration runs to commercial-scale production through a manufacturing partner in Europe, allowing the company to produce many tons of product over the next one to two years. Melt&Marble plans to launch its first commercial ingredients in 2026, beginning with personal care applications. Key regulatory registrations for beauty market entry have already been completed.
In parallel, the company is preparing regulatory filings for food applications. It is advancing the GRAS process in the United States and preparing for novel food authorization in Europe. This dual approach positions Melt&Marble to enter major global markets while continuing co-development projects with strategic partners.
The company estimates that its addressable market spans more than $100 billion across beauty, personal care, dairy alternatives, meat alternatives, bakery, confectionery, and specialized nutrition. As brands seek more sustainable, functional ingredients, precision-designed fats offer a significant competitive advantage.
With this Series A, Melt&Marble shifts from an R&D-led innovator to a commercial-stage company ready to influence the future of fats. Backed by leading investors, strong corporate partners, and a clear commercial roadmap, the company is preparing to bring its next-generation lipids to both food and beauty markets worldwide.